This report examines the differences between self-reported nicotine exposure and biological evidence from serum cotinine levels in US non-smokers. It highlights the importance of accurate exposure assessment for public health strategies.
Understanding these discrepancies can help improve policies aimed at reducing secondhand smoke exposure and protecting non-smokers from associated health risks.